Portal vein embolization: what do we know?

Details

Ressource 1Download: serval:BIB_A5C4F61C4C81.P001 (299.48 [Ko])
State: Public
Version: author
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
Serval ID
serval:BIB_A5C4F61C4C81
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Portal vein embolization: what do we know?
Journal
Cardiovascular and Interventional Radiology
Author(s)
Denys A., Prior J., Bize P., Duran R., De Baere T., Halkic N., Demartines N.
ISSN
1432-086X (Electronic)
ISSN-L
0174-1551
Publication state
Published
Issued date
2012
Peer-reviewed
Oui
Volume
35
Number
5
Pages
999-1008
Language
english
Notes
Publication types: Journal Article Publication Status: ppublish. PDF type: REVIEW ARTICLE
Abstract
Portal vein embolization (PVE) has been developed to increase the size of the future remnant liver (FRL) left in place after major hepatectomy, thus reducing the risk of postoperative liver insufficiency. PVE consist in embolizing preoperatively portal branches of the segments that will be resected. Indication is based on preoperative measurements of the FRL by computed tomography and its ratio with either the theoretical liver volume or by direct measurement of the functional liver volume. After PVE, the volume and function of the FRL increases in 3 to 6 weeks, permitting extensive resections in patients otherwise contraindicated for liver resection. The PVE technique is variable from one center to another; however n-butyl-cyano-acrylate provides an interesting compromise between hypertrophy rate and procedure risk.
Pubmed
Web of science
Open Access
Yes
Create date
01/03/2012 16:08
Last modification date
01/10/2019 6:19
Usage data